BCE1
Putative protein BCE-1
Also known as: BCE1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for BCE1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
84 residues, UniProt reviewed canonical sequence.
>O60756|BCE1
1 MGRTPTAVQV KSFTKQGQQR RVCRDLPLKN TKNGLSPGMR TCFLYLRFFP CLSWMSLKWT
61 QAVHCARNIV LSFMLLLLLL NYNMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCE1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCE1 as an antibody target. Whether an autoantibody or antibody against BCE1 could matter depends on whether native BCE1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCE1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCE1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...